Cosmetic Corner

Monitoring Acne Patients on Oral Therapy: Survey of the Editorial Board


 

References

Which pregnancy test do you perform on female patients taking isotretinoin?

More than 40% of dermatologists surveyed use the urine β-human chorionic gonadotropin (hCG) pregnancy test for female patients taking isotretinoin, while 30% use the serum B-hCG test; 28% indicated that they use both tests.

Expert Commentary
Provided by Shari R. Lipner, MD, PhD (New York, New York)

The iPLEDGE program was implemented in 2006 to avoid fetal exposure to isotretinoin and requires pregnancy testing (urine or serum) for females of childbearing potential taking isotretinoin. In a study of pregnancy-related adverse events associated with isotretinoin reported to the US Food and Drug Administration, 6740 total pregnancies were reported from 1997 to 2017. The rate peaked with 768 pregnancies in 2006 and then decreased. Because several hundred pregnancies in women taking isotretinoin have been reported yearly in the last 10 years, there is a clear need to have better systems in place and patient education to prevent fetal exposure to isotretinoin.

Next page: More tips from derms

Pages

Recommended Reading

Severe Acne Fulminans Following Low-Dose Isotretinoin and Testosterone Use
MDedge Dermatology
No increased risk of psychiatric problems tied to isotretinoin
MDedge Dermatology
Acne in women: What new insights tell us
MDedge Dermatology
What’s New in the Management of Acne Vulgaris
MDedge Dermatology
The Role of Adolescent Acne Treatment in Formation of Scars Among Patients With Persistent Adult Acne: Evidence From an Observational Study
MDedge Dermatology
Update on Diet and Acne
MDedge Dermatology
Acne before puberty: When to treat, when to worry
MDedge Dermatology
iPledge: Fetal exposure to isotretinoin continues
MDedge Dermatology
The ABCs of COCs: A Guide for Dermatology Residents on Combined Oral Contraceptives
MDedge Dermatology
Consider adding chemical peels for your acne patients
MDedge Dermatology